Symonds Toby Edgcumbe 4
4 · IPERIONX Ltd · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
IPERIONX (IPX) President Toby Symonds Receives Equity Awards
What Happened Toby Edgcumbe Symonds, President of IPERIONX Ltd (IPX), received three derivative equity grants on April 2, 2026 totaling 1,369,812 awards: 226,047; 536,521; and 607,244. The filing shows these are derivative instruments (options and/or performance rights) with no cash price reported (N/A), meaning they are awards rather than open‑market purchases or sales.
Key Details
- Transaction date: 2026-04-02; filing date / period of report: 2026-04-02 (filed same day).
- Awards granted: 226,047; 536,521; 607,244 — total 1,369,812 derivative awards.
- Price / value: N/A in the filing (these are grants, not purchases at a set market price).
- Vesting / conversion notes from the filing:
- Some awards have time-based vesting: 302,666 vest in Dec 2026; 400,533 vest in Apr 2028 (per footnote).
- Performance right conditions include four years of continuous service through 04/02/2030 and an ASX 30‑day VWAP of A$18 (per footnote).
- Options (where applicable) confer the right to purchase one ordinary share at the stated conversion price.
- Trading venues and units:
- Ordinary shares trade on the Australian Securities Exchange (ASX).
- American Depositary Shares (ADS) trade on Nasdaq; 1 ADS = 10 ordinary shares.
- Monetary references in the filing are in Australian Dollars (A$).
- Shares owned after transaction: not specified in the provided filing summary.
- Timeliness: filing appears timely (filed same day as the transaction).
Context These are compensation grants (derivative awards like performance rights or options) rather than open‑market purchases or sales. Such awards vest or convert only if time and/or performance conditions are met, so they do not represent an immediate cash outlay or sale by the insider. For retail investors, grants signal executive compensation alignment with future performance targets but should not be interpreted as an immediate bullish market signal.
Insider Transaction Report
- Award
Performance Rights (A$18)
[F5][F6][F1]2026-04-02+226,047→ 226,047 totalExercise: $18.00From: 2030-04-02Exp: 2031-04-02→ IPX Ordinary Shares (226,047 underlying) - Award
Options (A$18)
[F5][F7][F1]2026-04-02+536,521→ 536,521 totalExercise: $18.00From: 2030-04-02Exp: 2031-04-02→ IPX Ordinary Shares (536,521 underlying) - Award
Options (A$22)
[F5][F7][F1]2026-04-02+607,244→ 607,244 totalExercise: $22.00From: 2030-04-02Exp: 2031-04-02→ IPX Ordinary Shares (607,244 underlying)
- 3,188,146
Ordinary Shares
[F1] - 703,199
Restricted Stock Units
[F2] - 11,000
American Depository Shares (ADS)
[F3][F4][F1]→ IPX Ordinary Shares (110,000 underlying) - 1,110,000
Performance Rights (A$4)
[F5][F1]Exercise: $4.00From: 2027-12-21Exp: 2028-12-21→ IPX Ordinary Shares (1,110,000 underlying) - 415,695
Performance Rights (A$6)
[F5][F1]Exercise: $6.00From: 2029-04-10Exp: 2030-04-10→ IPX Ordinary Shares (415,695 underlying) - 415,695
Performance Rights (A$7)
[F5][F1]Exercise: $7.00From: 2029-04-10Exp: 2030-04-10→ IPX Ordinary Shares (415,695 underlying) - 415,695
Performance Rights (A$8)
[F5][F1]Exercise: $8.00From: 2029-04-10Exp: 2030-04-10→ IPX Ordinary Shares (415,695 underlying)
Footnotes (7)
- [F1]Ordinary Shares are traded on the Australian Stock Exchange (ASX).
- [F2]302,666 vest in December 2026; 400,533 vest in April 2028.
- [F3]American Depository Shares are traded on the Nasdaq.
- [F4]One ADS is equivalent and exchangeable into ten ordinary shares.
- [F5]Australian Dollars.
- [F6]Each performance right is convertible into one ordinary share after performance criteria have been met. Performance criteria are (1) four years of continuous service through 04/02/2030, and (2) IPX stock price on the ASX reaching a thirty-day volume-weighted average price (VWAP) of A$18.00.
- [F7]Each option confers the right to purchase one ordinary share at the conversion price.